Fennec Pharmaceuticals vs Sutro Biopharma
FENC and STRO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FENC and STRO compare
Fennec Pharmaceuticals is the larger company, worth 2.2 times as much as Sutro Biopharma ($373M against $170M).
Fennec Pharmaceuticals grew revenue faster over the last twelve months (77.8% versus −56.3% for Sutro Biopharma).
Fennec Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of −5.5% compared with −395% at Sutro Biopharma.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FENC | STRO |
|---|---|---|
| Size and price | ||
| Market cap | $373M | $170M |
| Share price | $10.64 | $10.26 |
| Change, 1 year | 38.5% | 27.3% |
| Change, 5 years | 8.3% | −94.2% |
| Beta (5Y) | 0.80 | 2.21 |
| Employees | 35 | 137 |
| StockData Score | ||
| Total score | 7 | 7 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 3 (better) | 0 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 6.3× | 3.7× (better) |
| P/B | 8.8× | – |
| Fair value | $7.12 | – |
| Margin of safety | −49.4% | – |
| Growth | ||
| Revenue growth (TTM) | 77.8% (better) | −56.3% |
| Revenue growth, 5Y average | 195% (better) | 19.1% |
| Profitability | ||
| Operating margin | −1.9% (better) | −320% |
| Net margin | −5.5% (better) | −395% |
| Return on equity | −18.6% | – |
| Financial health | ||
| Interest coverage | −1.2× | – |
| Current ratio | 5.85 (better) | 3.32 |
| Altman Z-score | 4.21 (better) | −8.74 |
| Piotroski F-score | 1 | 2 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 46.5% | 99.4% |
| Held by insiders | – | 6.1% |
| Insider net buying, 12 months | −$9.6M | $0 (better) |
| Short interest, % of float | – | 14.5% |
Go deeper
- FENC stock overview
- FENC income statement
- FENC valuation and score
- STRO stock overview
- STRO income statement
- STRO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.